FullHope Biomedical CoROCO:7773 14 EV-to-FCF is -31.87 as of Jul. 12, 2026. GuruFocus rates ROCO:7773 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 329 Biotechnology companies, FullHope Biomedical Co ranks worse than 303951.06% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, FullHope Biomedical Co's Enterprise Value is NT$779.88 Mil.
FullHope Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-24.47 Mil. Therefore, FullHope Biomedical Co's EV-to-FCF for today is -31.87.
The historical rank and industry rank for FullHope Biomedical Co's EV-to-FCF or its related term are showing as below:
ROCO:7773'
s EV-to-FCF Range Over the Past 10 Years
Min: -40.64 Med: -16.75 Max: -10.86
Current: -31.87
During the past 5 years, the highest EV-to-FCF of FullHope Biomedical Co was -10.86. The lowest was -40.64. And the median was -16.75.
ROCO:7773's EV-to-FCF is ranked worse than 100% of 329
companies
in the Biotechnology industry
Industry Median: 15.85
vs ROCO:7773: -31.87
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
FullHope Biomedical Co (ROCO:7773) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
FullHope Biomedical Co's PE Ratio (TTM) for today is calculated as:
FullHope Biomedical Co's share price for today is NT$27.65.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-0.980.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7773 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, FullHope Biomedical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FullHope Biomedical Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, FullHope Biomedical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where FullHope Biomedical Co's EV-to-FCF falls into.
FullHope Biomedical Co's current Enterprise Value is NT$779.88 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. FullHope Biomedical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-24.47 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FullHope Biomedical Co (ROCO:7773) has a EV-to-FCF of -31.87 as of Jul. 12, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on FullHope Biomedical Co and its competitors. According to the industry distribution chart, FullHope Biomedical Co ranks #999999 out of 329 companies in the Biotechnology industry.
Is FullHope Biomedical Co's EV-to-FCF too high?
FullHope Biomedical Co's current EV-to-FCF is -31.87. Based on the distribution chart, FullHope Biomedical Co ranks #999999 out of 329 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FullHope Biomedical Co has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does FullHope Biomedical Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FullHope Biomedical Co ranks #999999 out of 329 companies for EV-to-FCF. This places FullHope Biomedical Co in the lower half of its industry. The industry median EV-to-FCF is 15.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.85, based on 329 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on FullHope Biomedical Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FullHope Biomedical Co's current EV-to-FCF is -31.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FullHope Biomedical Co stock overvalued right now?
FullHope Biomedical Co (ROCO:7773) has a current EV-to-FCF of -31.87. The current EV-to-FCF is -31.87. FullHope Biomedical Co's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For FullHope Biomedical Co (ROCO:7773), the current EV-to-FCF is -31.87 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.
14GF Score
Get the complete analysis for ROCO:7773
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7773 has been successfully added to your 